The Journal of Immunology, Vol 150, Issue 3 1065-1073, Copyright © 1993 by American Association of Immunologists

ARTICLES

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent

P Joling, LJ Bakker, JA Van Strijp, T Meerloo, L de Graaf, ME Dekker, J Goudsmit, J Verhoef and HJ Schuurman
Department of Pathology, University Hospital, Utrecht, The Netherlands.

The authors studied the binding in vitro of HIV-1 virus particles, conjugated to fluorescein isothiocyanate, to follicular dendritic cells (FDC) isolated from human tonsils. Analysis was done using flow cytometry, fluorescence microscopy, and immunogold electron microscopy. The focus of study was on the effect of serum from various origins, including pooled fresh serum and heated serum from control donors and pooled heated serum from HIV-1-infected patients (containing anti-HIV-1 antibodies). In the presence of heated serum, either from controls or from HIV-1-infected patients, the fluorescence signal in flow cytometry was similar to the background value. In the presence of fresh serum, the signal was substantially increased, and an even higher signal was observed in the presence of fresh serum and serum from HIV-1-infected patients. This high fluorescence signal was also found in the presence of serum depleted of complement factor C5, but not with serum deficient in complement factor C3. The binding of HIV-1 virions to FDC in the presence of fresh serum was confirmed by fluorescence microscopy on cytospot preparations. After quenching of the extracellular fluorescence with trypan blue, the fluorescence was reduced to about 30% of the initial value, indicating that most of bound fluorescent virions were present extracellularly. Similar experiments using blood mononuclear cells showed that fluorescent HIV-1 particles after binding to these cells were present intracellularly. This flow cytometry data was confirmed in immunogold electron microscopy demonstrating that most HIV-1 gag p24 or FITC label was present at the outside of FDC and on adherent virus particles. We conclude that HIV-1 virions adhere to FDC in vitro in a complement component C3-dependent way. Anti-HIV-1 antibodies in serum from HIV-1 infected patients enhance binding but, by itself, are unable to mediate binding.

This article has been cited by other articles:

				B. Stojkovic, E. M. Torres, A. M. Prouty, H. K. Patel, L. Zhuang, T. M. Koehler, J. D. Ballard, and S. R. Blanke High-Throughput, Single-Cell Analysis of Macrophage Interactions with Fluorescently Labeled Bacillus anthracis Spores Appl. Envir. Microbiol., August 15, 2008; 74(16): 5201 - 5210. [Abstract] [Full Text] [PDF]

				J. Ho, S. Moir, L. Kulik, A. Malaspina, E. T. Donoghue, N. J. Miller, W. Wang, T.-W. Chun, A. S. Fauci, and V. M. Holers Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues J. Immunol., June 1, 2007; 178(11): 6968 - 6974. [Abstract] [Full Text] [PDF]

				H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi, J. Legoff, M. D. Kazatchkine, L. Belec, and H. Hocini Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner J. Immunol., January 15, 2007; 178(2): 1086 - 1095. [Abstract] [Full Text] [PDF]

				E. Horakova, O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli Complement Mediates the Binding of HIV to Erythrocytes J. Immunol., September 15, 2004; 173(6): 4236 - 4241. [Abstract] [Full Text] [PDF]

				C. J. Sigurdson, C. Barillas-Mury, M. W. Miller, B. Oesch, L. J. M. van Keulen, J. P. M. Langeveld, and E. A. Hoover PrPCWD lymphoid cell targets in early and advanced chronic wasting disease of mule deer J. Gen. Virol., October 1, 2002; 83(10): 2617 - 2628. [Abstract] [Full Text] [PDF]

				A. Malaspina, S. Moir, D. C. Nickle, E. T. Donoghue, K. M. Ogwaro, L. A. Ehler, S. Liu, J. A. M. Mican, M. Dybul, T.-W. Chun, et al. Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma J. Virol., July 29, 2002; 76(17): 8855 - 8863. [Abstract] [Full Text] [PDF]

				J. M. Guthridge, K. Young, M. G. Gipson, M.-R. Sarrias, G. Szakonyi, X. S. Chen, A. Malaspina, E. Donoghue, J. A. James, J. D. Lambris, et al. Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface J. Immunol., November 15, 2001; 167(10): 5758 - 5766. [Abstract] [Full Text] [PDF]

				L. Kacani, W. M. Prodinger, G. M. Sprinzl, M. G. Schwendinger, M. Spruth, H. Stoiber, S. Döpper, S. Steinhuber, F. Steindl, and M. P. Dierich Detachment of Human Immunodeficiency Virus Type 1 from Germinal Centers by Blocking Complement Receptor Type 2 J. Virol., September 1, 2000; 74(17): 7997 - 8002. [Abstract] [Full Text]

				S. Moir, A. Malaspina, Y. Li, T.-W. Chun, T. Lowe, J. Adelsberger, M. Baseler, L. A. Ehler, S. Liu, R. T. Davey , Jr., et al. B Cells of HIV-1-infected Patients Bind Virions through CD21-Complement Interactions and Transmit Infectious Virus to Activated T Cells J. Exp. Med., August 28, 2000; 192(5): 637 - 646. [Abstract] [Full Text] [PDF]

				J. J. Jakubik, M. Saifuddin, D. M. Takefman, and G. T. Spear Immune Complexes Containing Human Immunodeficiency Virus Type 1 Primary Isolates Bind to Lymphoid Tissue B Lymphocytes and Are Infectious for T Lymphocytes J. Virol., January 1, 2000; 74(1): 552 - 555. [Abstract] [Full Text]

				W. S. Hlavacek, C. Wofsy, and A. S. Perelson Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis PNAS, December 21, 1999; 96(26): 14681 - 14686. [Abstract] [Full Text] [PDF]

				P. Tacnet-Delorme, V. Boyer, N. M. Thielens, J.-F. Hernandez, I. Bally, R. B. Sim, C. Desgranges, and G. J. Arlaud In Vitro Analysis of Complement-Dependent HIV-1 Cell Infection Using a Model System J. Immunol., April 1, 1999; 162(7): 4088 - 4093. [Abstract] [Full Text] [PDF]